CD BioSciences

CD BioSciences is a biotechnology company based in New York that provides a comprehensive range of laboratory services and research products to support life science, drug discovery, and clinical development. The company leverages advanced technology and analytical expertise to offer services including bioanalytical testing, clinical pharmacology, statistical analysis, and biomarker validation. They also develop and manufacture specialized research products, such as transfection kits for in vitro and in vivo applications, and utilize sophisticated equipment for tasks like mass spectrometry, sequencing, and materials analysis. By integrating technical infrastructure with specialized scientific personnel, they aim to improve the efficiency, predictability, and quality of research trials and experimental workflows.

The company serves as a research partner for scientists and drug manufacturers globally, helping them navigate complex regulatory and operational challenges in areas such as oncology, immunology, and metabolic disease. Their focus on professional technical support, data accuracy, and rigorous quality control enables clients to accelerate research progress and optimize project outcomes. Through a broad portfolio of services and tailored research solutions, CD BioSciences addresses the needs of researchers at various stages of the development lifecycle, ranging from initial laboratory experimentation and molecular characterization to late-stage clinical trials.